Idiopathic Urticaria
📧 Sign up to get email alerts when something new happens for Idiopathic Urticaria.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-10-18FDA Approved: DESLORATADINE — Supplemental Application (Bionpharma Inc.)
FDA approves a supplemental application for Desloratadine from Bionpharma Inc., confirming the approval of the generic product under ANDA 07…
-
FDA approval · 2019-10-18FDA Approved: ALLERGY RELIEF — Original Application (WALMART INC. (see also Equate))
The FDA approved Walmart's original application for an over-the-counter allergy relief product containing fexofenadine hydrochloride (Allerg…
-
FDA approval · 2019-10-03FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Chewable Grape and Bubble Gum (loratadine) by Bayer HealthCare LLC, adding a flavor…
-
FDA approval · 2019-10-03FDA Approved: DESLORATADINE — Supplemental Application (Natco Pharma USA LLC)
The FDA approved a supplemental application for desloratadine from Natco Pharma USA LLC.
-
FDA approval · 2019-09-23FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals' generic levocetirizine dihydrochloride.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody [Phase 4]
Phase 4 trial update evaluating an anti-IL5Ralpha monoclonal antibody for chronic idiopathic urticaria unresponsive to H1 antihistamines.
-
FDA approval · 2019-06-28FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for levocetirizine dihydrochloride (Camber Pharmaceuticals, Inc.). The approval updates the product'…
-
FDA approval · 2019-05-07FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
The FDA approved a supplemental application for CLARITIN REDITABS (loratadine) from Bayer Healthcare LLC., likely authorizing a new or modif…
-
FDA approval · 2019-03-28FDA Approved: GOOD SENSE LEVOCETIRIZINE — Original Application (L. Perrigo Company)
The FDA approved the original application for Good Sense Levocetirizine (levocetirizine dihydrochloride) by L. Perrigo Company as a generic …
-
FDA approval · 2019-02-28FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin RediTabs (loratadine) from Bayer HealthCare LLC. The action adds a new formulation …
-
FDA approval · 2019-02-28FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
The FDA approved a supplemental application for Claritin RediTabs containing loratadine, introducing a new dosage form under Bayer Healthcar…
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria [NA]
This completed single-center trial investigated biomarkers and response to omalizumab (Xolair) therapy in chronic idiopathic urticaria. The …
-
FDA label_change · 2019-01-11FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) from Chattem, Inc., resulting in changes to the produ…
-
FDA approval · 2018-11-21FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add Claritin Chewable Grape and Bubblegum (loratadine) as a new chewable dosage form, expanding t…
-
FDA approval · 2018-10-03FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
FDA approved a supplemental application for Claritin (loratadine) from Bayer HealthCare LLC. The action approves changes to the product's la…
-
FDA approval · 2018-07-20FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Chewable Grape and Bubblegum (loratadine) from Bayer HealthCare LLC.
-
FDA approval · 2018-07-05FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin (loratadine) filed by Bayer HealthCare LLC.
-
FDA approval · 2018-05-21FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for a generic version of levocetirizine dihydrochloride from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2018-04-16FDA Approved: LORATADINE — Original Application (Chain Drug Consortium, LLC)
The FDA approved the original application for loratadine filed by Chain Drug Consortium, LLC, enabling a generic loratadine product to be ma…
-
FDA approval · 2018-04-11FDA Approved: LORATADINE ODT — Original Application (Aurohealth LLC)
FDA approved a generic loratadine orally disintegrating tablet (LORATADINE ODT) under ANDA 208477 with Aurohealth LLC as the sponsor. The pr…
-
FDA approval · 2018-04-02FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) filed by Chattem, Inc. The action confirms changes to the…
-
FDA approval · 2018-01-19FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Inc.)
The FDA approved Dr. Reddy's Laboratories' original ANDA for levocetirizine dihydrochloride, a generic antihistamine indicated for relief of…
-
FDA approval · 2017-12-27FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Vensun Pharmaceuticals, Inc.)
FDA approved a supplemental application for levocetirizine dihydrochloride (Vensun Pharmaceuticals, Inc.) under an ANDA. This action maintai…
-
FDA approval · 2017-09-18FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental ANDA for levocetirizine dihydrochloride from Teva Pharmaceuticals USA, Inc., expanding the availability of a gen…
-
FDA approval · 2017-09-18FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Levocetirizine dihydrochloride by Macleods Pharmaceuticals Limited under ANDA205564.